Merlin waves his biotechnological wand

April 3, 1998

Merlin Ventures, the biotechnology investment firm set up by academic-turned-entrepreneur Chris Evans, is pumping Pounds 10 million into three of its firms. ReNeuron, set up last year, will get Pounds 5 million for research at the Institute of Psychiatry, part of King's College London, on treatments for strokes, Alzheimer's and Parkinson's disease, and genetic disorders such as Huntingdon's disease.

Microscience, a spin-off of the Royal Postgraduate Medical School, will get Pounds 2.5 million for work on antimicrobial vaccines and drugs. Eurogene will get Pounds 3 million for work on cardiovascular disease at University College London and at Finland's Virtanen Institute.

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Please Login or Register to read this article.


Featured jobs

Head of Media Relations

Cranfield University

Customer Service Advisor

Bpp University

Clinic Secretary, Auditory Implant Service

University Of Southampton

Lecturer in Criminology

University Of Lincoln

Resourcing Administrator

Bpp University